Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.
Also called NCT03547323
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 156 participants
- Registry
-
NCT03547323
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03547323. Randomized; no masking; primary purpose treatment. Start 2018-09-14 (actual); primary completion 2019-06-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer
- Condition
- End Stage Renal Disease
- Intervention (Device)
- Theranova 400 Dialyzer
- Intervention (Device)
- FX80 Dialyzer
- Lead sponsor
- Vantive Health LLC
- Collaborator
- Baxter Healthcare Corporation
Record details
- Record id
cardio:ct-nct03547323- Content hash
ebe791410b7153ed248fcefe09d5f89317e2900d2437699ca6b9aa30b7804677